Zeta Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 3350.18%
(FY 2018)
- Profit 136.74%
(FY 2018)
- Ebitda 137.18%
(FY 2018)
- Net Worth 5.60%
(FY 2018)
- Total Assets 11.62%
(FY 2018)
About Zeta Life Sciences
The Corporate was formerly known as Nexgen Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhay Jain and Ravi Jain serve as directors at the Company.
- CIN/LLPIN
U24230CH2005PTC028387
- Company No.
028387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zeta Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Jain  | Director | 10-May-2005 | Current |
| Ravi Jain | Director | 10-May-2005 | Current |
Financial Performance of Zeta Life Sciences.
Zeta Life Sciences Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 3350.18% increase. The company also saw a substantial improvement in profitability, with a 136.74% increase in profit. The company's net worth moved up by a moderate rise of 5.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeta Life Sciences?
In 2018, Zeta Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Evermark Developers And Promoters Private LimitedActive 4 years 2 months
Abhay Jain and Ravi Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zeta Life Sciences?
Unlock and access historical data on people associated with Zeta Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeta Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeta Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
